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Background: Temporomandibular joint (TMJ) involvement occurs in up to 80% of patients with juvenile idiopathic
arthritis (JIA). Currently there are no standardized procedures regarding diagnosis and treatment of this common
complication of JIA. The aim of the study was to assess the current clinical practices in many countries regarding
diagnosis and treatment of TMJ involvement in JIA. Pediatric rheumatologists were asked to fill out a survey with 8
items regarding diagnosis and treatment of TMJ involvement. The survey was distributed over the worldwide
pediatric rheumatology electronic list-serve. Data was collected in an Excel spread sheet and analyzed using Excel
software.
Findings: Eighty-seven centers responded to the survey between December 2009 and April 2010. All responding
centers were actively screening for TMJ involvement. All centers were screening by physical exam, 85 (97%) by
history, and 2 (3%) by imaging. Seventy-seven (88%) centers were screening at the first visit and 76 (87%) at each
follow-up visit. If imaging was requested, 77% of the centers reported that they asked for MRI, 10% for ultrasound,
9% for CT and 33% for X-ray. The first line treatment of TMJ arthritis was a non-biologic DMARD in 36%, an NSAID
in 33%, an intraarticular corticosteroid injection in 26%, and an anti-TNF agent in 5%. Overall, 57 (65%) of the centers
were using intraarticular corticosteroid injections as treatment.
Conclusions: TMJ arthritis is common among children with JIA. This survey shows that a wide array of diagnostic
and therapeutic approaches is being employed for TMJ disease in 87 international centers. Due to this lack of
agreement in how to diagnose and treat this JIA complication, we believe that an expert opinion/consensus
statement regarding TMJ arthritis in JIA will likely benefit patients worldwide.Background
Temporomandibular joint (TMJ) arthritis occurs in up
to 80% of patients with juvenile idiopathic arthritis (JIA)
by MRI assessment, but it is asymptomatic in up to 70%
of the patients [1,2]. The diagnosis of TMJ involvement
in JIA is still difficult [3]. The range of the reported
prevalence is wide, and it depends to a large part on the
method of assessment of TMJ arthritis. The sensitivity
and specificity of the clinical examination by pediatric
rheumatologists and different imaging methods leads to
a wide range of reported TMJ involvement [4,5]. A re-
cent publication in which even clinically quiet TMJs* Correspondence: foeldvari@t-online.de
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reproduction in any medium, provided the orwere imaged by MRI found the highest prevalence of
TMJ arthritis [1]. There is even less known about ideal
therapy for TMJ arthritis once it is diagnosed in children
with JIA.
To date, there is only one small prospective study
reporting on the treatment of TMJ arthritis exclusively
[6]. In clinical experience TMJs appear to respond less
well to the standard of care used to treat other joints.
This is reflected in the study populations of Ringold
et al. [6] and Arabshahi et al. [7]. In these studies, a large
proportion of patients received a DMARD plus anti-
TNF treatment, and despite these therapies, patients
developed TMJ arthritis. These publications included
intraarticular corticosteroid treatment of TMJ arthritis
and demonstrated a response in subsets of the JIA pa-
tients [6,7], but not all of the treated JIA patients regainal Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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timing of the treatments. Currently they are no stan-
dardized protocols regarding diagnosis and medical
treatment of this common presentation of JIA. To gain
more information about the current practice standards
regarding diagnosis and medical management of TMJ
arthritis in children with JIA, a multinational email sur-
vey was conducted.Methods
Pediatric rheumatologists, each one representing a unique
pediatric rheumatology center, were asked to fill out a sur-
vey with 8 items regarding diagnosis and medical treat-
ment of TMJ arthritis. They were asked about the size of
the clinic population and the proportion of JIA patients
having TMJ arthritis as assessed clinically and by imaging.
The questionnaire is attached in the Additional file 1. The
survey was distributed over the worldwide pediatric
rheumatology electronic list-serve similar to other surveys
[8]. Data was collected on an Excel spread sheet and ana-
lyzed using Excel software. It was stored on the firstFigure 1 Screening for TMJ arthritis. The percentages of centers screeni
(P.E.) or history (Hx) are shown on the left hand side of the bar graph. Of th
percentages of the centers using the various imaging modalities [MRI, Xray
the right hand side of the bar graph. More than one imaging modality perauthor’s computer and simple statistics were applied using
Excel.
The data was originally evaluated using only the first
77 centers responding. This data was compared to re-
sponses from the eventual total 87 worldwide centers.
Reassuringly, neither the answers nor the distribution of
the answers changed (data not shown).Findings
Eighty-seven centers responded to the survey from
December 2009 through March 2010, centers mostly
from mainland Europe, United Kingdom, United States,
and Canada. This represents about 10% of the participat-
ing centers on the pediatric rheumatology electronic list-
serve. Forty-three of the centers followed less than 300
patients with JIA, and 44 centers cared for more than
300 patients with JIA. Specifically, 27 centers followed
300 to 499 patients, 12 centers followed 500 to 1,000 pa-
tients, and 5 centers followed over 1,000 patients with
JIA. All responding centers were actively screening for
TMJ involvement (Figure 1).ng for TMJ arthritis among their JIA cohorts by either physical exam
ose centers that used imaging as screening for TMJ arthritis, the
(including orthopantomogram), ultrasound (UTZ), CT] are noted on
center may be employed.
Figure 3 Distribution of the different first line treatments for
TMJ arthritis at the various centers. The percentages of centers
using systemic anti-TNF treatment (blue), intraarticular corticosteroids
(red), NSAIDs (green), and non-biologic DMARDs (purple) for first line
therapy of TMJ arthritis among their respective JIA cohorts are
shown in the pie graph.
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by history, and all responding centers screened by phys-
ical exam. Only 2 centers primarily used imaging to
screen for TMJ arthritis. Seventy-seven (88%) centers
were screening all patients at the first clinical visit, irre-
spective of a positive history for TMJ involvement.
Seventy-six centers (87%) were screening all patients at
each follow-up visit, irrespective of a positive history of
TMJ involvement. If imaging for TMJ involvement was
requested for a suspicion of TMJ arthritis, 77% of centers
asked for MRI, 10% for ultrasound, 9% for computerized
tomography (CT), and 33% for standard radiography
(X-ray); some centers used more than one method for
screening for the arthritis (Figure 1). The centers reported
the following prevalence of TMJ arthritis (Figure 2): over
50% with TMJ arthritis in 4% of the centers; between 25
and 49% involvement in 11% of the centers; between 10%
and 24% involvement in 52% of the centers; and less than
10% involvement in 33% of the centers.
The first line medical treatment for TMJ arthritis
(Figure 3) was a non-biologic DMARD in 36%, an
NSAID in 33%, an intra-articular corticosteroid injec-
tion in 26%, and a systemic anti-TNF agent in 5% of the
patients. Overall, 57 of the centers (65%) were using
intraarticular corticosteroid injections as treatment at
some point in their treatment algorithm. Of the 57 cen-
ters, 32 (56%) were using imaging as guidance for the
intraarticular TMJ injection. Twenty centers provided
details about imaging for the TMJ injections. For these
20 centers, MRI was used in 10%, CT in 30%, ultra-
sound in 45%, and fluoroscopy in 15%. In 7 centers the
injection was performed by an oral surgeon or aFigure 2 The perceived prevalence of TMJ arthritis among the
JIA cohorts at the various centers. The percentages of centers
reporting >50% of their JIA cohort with TMJ arthritis (blue), 25-49%
with TMJ arthritis (red), 10-24% with TMJ arthritis (green), and <10%
with TMJ arthritis (purple) are noted in the pie graph.pediatric dentist; in these centers no information about
imaging during the procedure was given.
Discussion
The aim of this survey was to assess current clinical
practice for diagnosis and treatment of TMJ arthritis in
children with JIA. TMJ arthritis is common among those
with JIA, but a wide array of diagnostic and medical
therapeutic approaches are being employed by pediatric
rheumatologists according to this survey. It is encour-
aging that most responders screen for TMJ involvement,
but there may be a bias that centers who do not consider
TMJ involvement as an important issue did not respond
to the survey. It is likely that the centers that frequently
consider TMJ involvement in JIA, and how to screen and
diagnose TMJ arthritis, may have answered the survey
while those centers that are less interested did not.
The prevalence of TMJ arthritis in the different centers
appears to be widespread, which likely reflects the differ-
ent sensitivities of the applied screening methods. Most
of the responding centers screened for TMJ arthritis by
history and physical examination. We did not ask what
items of the history and physical were assessed. A recent
study showed that decreased mouth opening and lateral
protrusion of the chin seems to be most sensitive clinic-
ally [9]. Applied questions for orofacial symptoms have
not been previously assessed [10]. Unfortunately, we
cannot judge from our data how sensitive the clinical
history and the physical examination are for detecting
early TMJ involvement.
However, it is remarkable that a large proportion of
the centers still use X-ray for imaging of early TMJ
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for early changes of TMJ arthritis is well known. Radio-
graphs appear to be better suited for studying TMJ bony
changes later in the disease course [11]. Although ultra-
sound appears to be not nearly as sensitive as MRI at
detecting early TMJ arthritis signs [1,4], ultrasound ap-
pears to be still used at some centers for first line im-
aging [5] for unclear reasons. Thus, a variety of imaging
screening methods with different sensitivities for detect-
ing early TMJ arthritis are being used for detection of
TMJ arthritis in children with JIA. Unfortunately, in our
survey we did not ask if MRI of the TMJ was done with
or without gadolinium. A recent study of note suggested
that normal children without JIA may have some uptake
of gadolinium in the TMJ; however, the significance of
this finding is not yet clearly understood [12].
This survey also revealed that first line medical treat-
ment for TMJ arthritis in children with JIA included a
wide range of different classes of medications. This
might reflect different severities of the treated TMJ arth-
ritis and the different modalities used to detect TMJ
arthritis. As the question in the survey clearly asks for
the first line treatment, we would assume the response
likely reflects treatment of early disease. Also, there was
no information about additional joint involvement pro-
vided by the responders and treatment described ap-
peared to be directed at TMJ disease.
Intraarticular steroids for TMJ involvement were
employed in 65% of the responding centers. It is possible
that some centers are hesitant to use intraarticular ste-
roids due to animal model data in rabbits showing arrest
of the mandibular growth plate after intraarticular cor-
ticosteroid injection [13]. This risk was not confirmed in
another animal study or in a study on humans [2,14]. It
could also be that some centers do not have the expert-
ise and experience to do these injections. In addition,
the imaging modality used for guidance during intraarti-
cular steroid injections into the TMJ was varied. These
differences may reflect local availability, ease of various
forms of imaging guidance, the requirement for sedation,
or even costs involved. Finally, the benefit of intraarticu-
lar steroid application is not fully proven yet and is not
fully evidence-based [15]. Our survey did not assess
physiotherapy and the orthodontic treatment options in
the treatment of TMJ arthritis. We also did not assess
the use of biologic intraarticular injections for TMJ dis-
ease [16]. Future surveys may be valuable in defining
these gaps in data and level of detail.
Conclusions
TMJ arthritis is common among children with JIA. We
surveyed 87 pediatric rheumatologists demonstrating a
wide array of diagnostic and therapeutic approaches
for TMJ involvement in JIA. We are aware that asparticipation in the survey was voluntary it is likely
that physicians more interested in TMJ involvement
participated. Due to a lack of agreement in how to
diagnose and treat TMJ arthritis in JIA as demon-
strated in this survey, we believe that an expert opin-
ion/consensus statement regarding TMJ arthritis in JIA
will likely benefit patients worldwide.
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